Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Busulfan-induced hemorrhagic cystitis.

D Pode, S Perlberg, D Steiner

    The Journal of Urology
    |August 1, 1983
    PubMed
    Summary

    Prolonged busulfan therapy can cause severe hemorrhagic cystitis, a rare but serious complication. Early recognition and immediate discontinuation of busulfan are crucial for patient management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Disseminated osteolytic lesions in a 28-year-old refugee].

    Der Internist·2017
    Same author

    Scalp reconstruction: A 10-year retrospective study.

    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery·2017
    Same author

    A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.

    HLA·2016
    Same author

    Comparative validation of computer programs for haplotype frequency estimation from donor registry data.

    Tissue antigens·2013
    Same author

    Familial haplotyping and embryo analysis for Preimplantation genetic diagnosis (PGD) using DNA microarrays: a proof of principle study.

    Journal of assisted reproduction and genetics·2013
    Same author

    Imaging of chronic inflammatory bowel disease with 18F-FDG PET in children and adolescents.

    Klinische Padiatrie·2013

    Area of Science:

    • Oncology
    • Urology
    • Pharmacology

    Background:

    • Busulfan is a chemotherapy agent used in treating various cancers.
    • Hemorrhagic cystitis is a known complication of certain chemotherapy agents and radiation therapy.
    • The pathogenesis of chemotherapy-induced cystitis often involves urothelial damage.

    Observation:

    • A patient developed severe hemorrhagic cystitis following extended busulfan administration.
    • The clinical presentation and pathological findings mirrored those typically seen in cyclophosphamide or irradiation-induced cystitis.
    • This represents the second reported case of busulfan-induced hemorrhagic cystitis in medical literature.

    Findings:

    • Busulfan, particularly with prolonged use, can induce severe hemorrhagic cystitis.
    • The cystitis presents similarly to that caused by other cytotoxic agents, suggesting a common underlying mechanism of urothelial toxicity.
    • This complication, though rare, is a significant adverse event associated with busulfan therapy.

    Implications:

    • Hemorrhagic cystitis should be considered in the differential diagnosis for patients on prolonged busulfan therapy presenting with urinary symptoms.
    • Immediate cessation of busulfan is recommended upon suspicion or diagnosis of busulfan-induced hemorrhagic cystitis.
    • Further research may be warranted to elucidate the precise mechanisms and risk factors for busulfan-induced urotoxicity.

    Related Experiment Videos